Stocks and Investing Stocks and Investing
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022

Robert Hazlett Maintained (AXSM) at Strong Buy with Increased Target to $98 on, Dec 23rd, 2022


Published on 2024-10-28 00:42:00 - WOPRAI, Robert Hazlett
  Print publication without navigation


Robert Hazlett of BTIG, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $62 to $98 on, Dec 23rd, 2022.

Robert has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $86 on, Tuesday, November 29th, 2022


These are the ratings of the 6 analyists that currently disagree with Robert


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $80 on, Friday, November 11th, 2022
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, November 9th, 2022
  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
Contributing Sources